Department of Infectious Diseases

Medicine & Life Sciences

1. Acquired Immunodeficiency Syndrome 8%
2. Anti-Bacterial Agents 5%
3. Antibodies 10%
4. Antiviral Agents 15%
5. Bacteremia 17%
6. Bacterial Meningitides 5%
7. Biomarkers 6%
8. Cardiovascular Diseases 5%
9. CD4 Lymphocyte Count 17%
10. Cell Culture Techniques 11%
11. Child 8%
12. Chronic Hepatitis B 5%
13. Chronic Hepatitis C 19%
14. Chronic Obstructive Pulmonary Disease 5%
15. Cohort Studies 47%
16. Coinfection 5%
17. Communicable Diseases 5%
18. Comorbidity 10%
19. Confidence Intervals 20%
20. Coronavirus 28%
21. Coronavirus Infections 7%
22. Cross-Sectional Studies 7%
23. Delivery of Health Care 7%
24. Denmark 72%
25. Epitopes 7%
26. Fecal Microbiota Transplantation 5%
27. Fibrosis 6%
28. Genes 5%
29. Genome 6%
30. Genotype 31%
31. GS-5734 10%
32. Guidelines 5%
33. Health 6%
34. Hepacivirus 75%
35. Hepatitis 6%
36. Hepatitis B virus 5%
37. Hepatitis C 9%
38. Highly Active Antiretroviral Therapy 18%
39. HIV 100%
40. HIV Infections 22%
41. HIV-1 30%
42. Hospitalization 5%
43. Incidence 15%
44. Infections 25%
45. Inflammation 5%
46. Lipodystrophy 7%
47. Liver 6%
48. Liver Diseases 5%
49. Logistic Models 5%
50. Lung 5%
51. Meningitis 7%
52. Mortality 25%
53. Mutation 9%
54. Neutralizing Antibodies 12%
55. Observational Studies 6%
56. Odds Ratio 9%
57. Pandemics 5%
58. Pharmaceutical Preparations 7%
59. Placebos 7%
60. Pneumococcal Infections 7%
61. Pneumonia 10%
62. Population 22%
63. Prospective Studies 5%
64. Protease Inhibitors 9%
65. Proteins 5%
66. Randomized Controlled Trials 9%
67. Refugees 18%
68. Registries 5%
69. Retrospective Studies 5%
70. Ribavirin 7%
71. RNA 13%
72. SARS Virus 20%
73. Serogroup 5%
74. Severe Acute Respiratory Syndrome 16%
75. Staphylococcus aureus 10%
76. Systematic Reviews 7%
77. T-Lymphocytes 13%
78. Therapeutics 17%
79. Tuberculosis 12%
80. Urokinase Plasminogen Activator Receptors 8%
81. Vaccination 10%
82. Vaccines 18%
83. Viral Load 9%
84. Virion 5%
85. Virus Diseases 17%
86. Viruses 20%